Drug Shortage Report for JAMP-ROSUVASTATIN

Last updated on 2018-02-20 History
Report ID 23980
Drug Identification Number 02391287
Brand name JAMP-ROSUVASTATIN
Common or Proper name Rosuvastatin
Company Name JAMP PHARMA CORPORATION
Market Status DORMANT
Active Ingredient(s) ROSUVASTATIN
Strength(s) 40.0MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-09-01
Estimated end date
Actual end date 2018-02-19
Shortage status Resolved
Updated date 2018-02-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2018-02-20 French Compare
v20 2018-02-20 English Compare
v19 2018-01-29 French Compare
v18 2018-01-29 English Compare
v17 2017-12-22 French Compare
v16 2017-12-22 English Compare
v15 2017-12-22 French Compare
v14 2017-12-22 English Compare
v13 2017-12-22 French Compare
v12 2017-12-22 English Compare
v11 2017-12-22 French Compare
v10 2017-12-22 English Compare
v9 2017-12-22 French Compare
v8 2017-12-22 English Compare
v7 2017-12-11 French Compare
v5 2017-12-11 English Compare
v6 2017-12-11 English Compare
v4 2017-12-11 French Compare
v3 2017-12-11 English Compare
v2 2017-09-29 French Compare

Showing 1 to 20 of 21